Comorbidity and its Impact on COVID-19 Positive Patients who Died in Malaysia
| Autor: | Monica Danial, Ann Lisa Arulappen, Shahrul Aiman Bin Soelar, Alan Swee Hock Ch'ng, Irene Looi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| DOI: | 10.5281/zenodo.5357075 |
| Popis: | Background Battling the COVID-19 pandemic still is the main agenda of many countries in the world today. This study evaluated the association between comorbidities and its impact on COVID-19 mortality. Method The public data set of the COVID-19 patient who passed away in 2020 in Malaysia due to COVID-19 was obtained from the daily press statement by the Ministry of Health Malaysia (MOH). Results Incidence of gout was more prevalent among patients ≥65 years (n=14 (6.1%)) and significantly associated with mortality (p=0.011), whereas obesity (n=14 (5.8%); p=0.003) and asthma (n=11 (4.5%); p=0.040) were more prevalent and significantly associated with mortality among patients Conclusion Conclusively, there is a high incidence of comorbidities hypertension and diabetes mellitus among COVID-19 patients who died in Malaysia in 2020, but there is a small proportion of deaths among patients without pre-existing comorbidities. [Disclaimer: Abstract text might vary slightly from what is displayed in the e-poster] This poster was submitted to the 14th National Conference for Clinical Research (NCCR) in August 18-20, 2021. https://nccrconference.com.my/ |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|